The legalization of the consumption of Cannabis products in 35 states and the District of Columbia, with an additional eleven states decimalizing Cannabis creating a “legal” market expected to exceed $25 B by 2024 and $57 B by 2027.
Why? THCG and CNBG, found in cannabis and hemp plants, under heat, converts to THC and or CNB providing some measure of psychotropic experiences for the consumer and the potential of medical treatment for a variety of maladies.
Typically, a strain of a cannabis plant will have differing strengths of both elements, and experienced consumers will have their favorite strains, as well as blends of their favorite strains. The largest growing sector of the consumable cannabis products are vapes and edibles with cannabis based extracts and oils either added or infused in the consumable product offerings.
In addition to the consumption for the recreational “high”, or the capacity to “zone out” to permit sleep, there is a growing public conviction that the medical benefits for applications of cannabis derived products may eventually surpass recreational use. Big Pharma is placing current bets, as well as food and beverage companies, by “buying” interests in promising companies. The Canadian companies targeting the industry reflect the optimism with now multi- billion dollar market caps on the “promise” of future earnings.
Treatments for epilepsy, pain management, eye disease, and various nerve disorders are achieving medical efficacy. The US Federal Government placed their first order for 2.5 M pounds of cannabis product in 2018 for medical testing purposes, and several states, led by NY have encouraged medical doctors to write scripts for cannabis substitutes for pain management instead of opioids.
In the US, no vendor may cross state lines to sell their product. No federal banking institute can open an account for a cannabis cultivator, processor or distributor. Any product with over 3% THC is still on a federal controlled substance ban. And yet, literally billions of dollars are being wagered on the eventual legitimation of the entire industry and the elimination of the federal ban.
The legalization of the consumption of Cannabis products in 35 states and the District of Columbia, with an additional eleven states decimalizing Cannabis creating a “legal” market expected to exceed $25 B by 2024 and $57 B by 2027.
Why? THCG and CNBG, found in cannabis and hemp plants, under heat, converts to THC and or CNB providing some measure of psychotropic experiences for the consumer and the potential of medical treatment for a variety of maladies.
Typically, a strain of a cannabis plant will have differing strengths of both elements, and experienced consumers will have their favorite strains, as well as blends of their favorite strains. The largest growing sector of the consumable cannabis products are vapes and edibles with cannabis based extracts and oils either added or infused in the consumable product offerings.
In addition to the consumption for the recreational “high”, or the capacity to “zone out” to permit sleep, there is a growing public conviction that the medical benefits for applications of cannabis derived products may eventually surpass recreational use. Big Pharma is placing current bets, as well as food and beverage companies, by “buying” interests in promising companies. The Canadian companies targeting the industry reflect the optimism with now multi- billion dollar market caps on the “promise” of future earnings.
Treatments for epilepsy, pain management, eye disease, and various nerve disorders are achieving medical efficacy. The US Federal Government placed their first order for 2.5 M pounds of cannabis product in 2018 for medical testing purposes, and several states, led by NY have encouraged medical doctors to write scripts for cannabis substitutes for pain management instead of opioids.
In the US, no vendor may cross state lines to sell their product. No federal banking institute can open an account for a cannabis cultivator, processor or distributor. Any product with over 3% THC is still on a federal controlled substance ban. And yet, literally billions of dollars are being wagered on the eventual legitimation of the entire industry and the elimination of the federal ban.
Sign up our newsletter to get update information, promotion and insight
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.
Sign up our newsletter to get update information, promotion and insight